Vital Chemtech

Which are the latest news on Vital Chemtech?

Why is Vital Chemtech Ltd falling/rising?

As of 05-Sep, Vital Chemtech Ltd's stock price is rising to 55.72, reflecting a 2.26% increase due to strong relative performance and increased investor interest. Despite long-term challenges, the current upward trend is supported by improved quarterly sales and operational efficiency.

As of 05-Sep, Vital Chemtech Ltd's stock price is rising, currently at 55.72, reflecting a change of 1.23 or 2.26% increase. This upward movement can be attributed to several positive factors. The stock has outperformed its sector by 1.99% today, indicating strong relative performance. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bullish trend.<BR><BR>Investor participation has also increased significantly, with a delivery volume of 47.33k on 03 Sep, marking a rise of 1000.21% compared to the 5-day average. This surge in trading activity indicates growing interest among investors. Furthermore, the company reported its highest quarterly net sales at Rs 43.68 crore and a peak operating profit to net sales ratio of 8.97%, which reflects improved operational efficiency.<BR><BR>Despite these positive indicators, it is important to note that the company has faced challenges in the long term, including a -21.83% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 6.17 times. However, the current rise in stock price appears to be driven by short-term performance improvements and increased investor engagement.

Should I buy, sell or hold Vital Chemtech Ltd?

Who are in the management team of Vital Chemtech?

The management team of Vital Chemtech includes Vipul Jatashanker Bhatt (Chairman & Managing Director), Jay Vipul Bhatt and Sangeeta Vipul Bhatt (Whole-time Directors), Deepakkumar Kushalchandra Chaubisa and Hetalkumar Jayantilal Shah (Non-Executive & Independent Directors), and Puja Paras Mehta (Company Secretary).

The management team of Vital Chemtech includes the following individuals:<BR><BR>1. **Vipul Jatashanker Bhatt** - Chairman & Managing Director<BR>2. **Jay Vipul Bhatt** - Whole-time Director<BR>3. **Sangeeta Vipul Bhatt** - Whole-time Director<BR>4. **Deepakkumar Kushalchandra Chaubisa** - Non-Executive & Independent Director<BR>5. **Hetalkumar Jayantilal Shah** - Non-Executive & Independent Director<BR>6. **Puja Paras Mehta** - Company Secretary<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Vital Chemtech do?

Vital Chemtech Ltd is a Micro Cap company in the Chemicals & Petrochemicals industry, reporting net sales of 51 Cr and a net profit of 3 Cr for the quarter ending June 2026. The company has a market cap of INR 133 Cr and key financial metrics include a P/E ratio of 41.00 and a debt-equity ratio of 0.61.

Overview:<BR>Vital Chemtech Ltd operates in the Chemicals & Petrochemicals industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was originally incorporated as a Private Limited Company in 2013, underwent a status change to a Limited Liability Partnership in 2015, and reported net sales and profit for the quarter ending June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 51 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 3 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 133 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 41.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.61 <BR>Return on Equity: 1.04% <BR>Price-to-Book: 1.34 <BR><BR>Contact Details:<BR>Address: Not available <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Vital Chemtech?

Vital Chemtech's peers include Mahickra Chem., Indian Phosphate, Arvee Laborat., Jocil, Par Drugs & Che., and others. In terms of management risk, growth, and capital structure, Vital Chemtech ranks below average compared to its peers, with a 1-year return of -7.72%.

Peers: The peers of Vital Chemtech are Mahickra Chem., Indian Phosphate, Arvee Laborat., Jocil, Par Drugs & Che., Hindcon Chemical, Paragon Fine, Indian Emuls, Unilex Colour &C, and Nilachal Carbo.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indian Phosphate, Jocil, and Par Drugs & Che., while Average management risk is found at Mahickra Chem., Hindcon Chemical, and Indian Emuls, and Below Average management risk is noted at Arvee Laborat., Vital Chemtech, Unilex Colour &C, and Nilachal Carbo. Growth ratings show Excellent growth at Indian Emuls, while Average growth is seen at Mahickra Chem., Indian Phosphate, Hindcon Chemical, and the rest, and Below Average growth is present at Arvee Laborat., Jocil, Vital Chemtech, Par Drugs & Che., Paragon Fine, and Unilex Colour &C. In terms of Capital Structure, Excellent ratings are given to Indian Phosphate, Jocil, Par Drugs & Che., and Paragon Fine, Good ratings to Arvee Laborat. and Hindcon Chemical, and Below Average ratings to Mahickra Chem., Vital Chemtech, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mahickra Chem. at 85.80%, while the lowest is Indian Emuls at -70.55%, with Vital Chemtech's own 1-year return at -7.72% being significantly lower than Mahickra Chem. and higher than Indian Emuls. Additionally, Hindcon Chemical, Paragon Fine, Indian Emuls, Unilex Colour &C, and Nilachal Carbo all have negative six-month returns.

How big is Vital Chemtech?

As of 31st August, Vital Chemtech Ltd has a market capitalization of 133.00 Cr, with net sales of 146.88 Cr and a net profit of 3.08 Cr reported in the latest four quarters. The company has shareholder's funds of 92.14 Cr and total assets of 181.64 Cr for the annual period ending in March 2025.

As of 31st August, Vital Chemtech Ltd has a market capitalization of 133.00 Cr, classifying it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported net sales of 146.88 Cr and a net profit of 3.08 Cr.<BR><BR>For the latest annual period ending in March 2025, Vital Chemtech had shareholder's funds amounting to 92.14 Cr and total assets of 181.64 Cr.

Is Vital Chemtech overvalued or undervalued?

As of November 18, 2025, Vital Chemtech is considered very expensive and overvalued with a PE Ratio of 30.13, despite being lower than some peers, as it has underperformed significantly with a year-to-date return of -22.02% compared to the Sensex's gain of 9.58%.

As of 18 November 2025, the valuation grade for Vital Chemtech has moved from attractive to very expensive, indicating a significant shift in its market positioning. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 30.13, an EV to EBITDA of 19.72, and a Price to Book Value of 1.47, all of which suggest a premium valuation compared to industry norms.<BR><BR>In comparison to its peers, Vital Chemtech's PE Ratio is notably lower than that of Solar Industries at 94.24 and Gujarat Fluoroch at 57.77, but still higher than Godrej Industries, which is rated attractive with a PE of 37.03. The company's recent stock performance has been poor, with a year-to-date return of -22.02%, significantly underperforming the Sensex's gain of 9.58% during the same period, reinforcing the notion that the stock may be overvalued in the current market context.

How has been the historical performance of Vital Chemtech?

Vital Chemtech has experienced significant sales growth from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, despite profitability challenges and fluctuating cash flows, including a loss in Mar'24. Total assets increased from 81.25 Cr to 181.64 Cr during the same period, indicating overall growth despite rising raw material costs.

Answer:<BR>The historical performance of Vital Chemtech shows significant fluctuations in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Vital Chemtech's net sales increased from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, demonstrating strong growth, despite a dip to 98.27 Cr in Mar'24. Total operating income followed a similar trend, reaching 133.90 Cr in Mar'25 after a peak of 116.74 Cr in Mar'23. However, raw material costs surged from 38.11 Cr in Mar'22 to 107.39 Cr in Mar'25, impacting profitability. Operating profit (PBDIT) fluctuated, peaking at 14.92 Cr in Mar'23 but dropping to 13.35 Cr in Mar'25, while profit before tax saw a decline to 6.21 Cr in Mar'25 from 11.48 Cr in Mar'23. The profit after tax also reflected this volatility, with a loss of 1.30 Cr in Mar'24 turning into a profit of 4.06 Cr in Mar'25. The total assets of the company increased significantly from 81.25 Cr in Mar'22 to 181.64 Cr in Mar'25, alongside total liabilities rising from 81.25 Cr to 181.64 Cr in the same period. Cash flow from operating activities improved to 6.00 Cr in Mar'25, although the net cash inflow remained at 0.00 Cr, indicating challenges in cash management. Overall, while Vital Chemtech has shown growth in sales and assets, it has faced profitability challenges and fluctuating cash flows.

Who are the top shareholders of the Vital Chemtech?

The top shareholders of Vital Chemtech include promoter Vipul Bhatt, who holds 55.11% of the shares, with no pledged holdings. Other notable shareholders are three foreign institutional investors with 1.78% combined and Craft Emerging Market Fund Pcc- Elite Capital Fund, the highest public shareholder at 1.62%.

The top shareholders of Vital Chemtech include the promoters, with Vipul Bhatt being the largest individual shareholder, holding 55.11% of the company's shares. There are no pledged promoter holdings reported. In addition, the company has three foreign institutional investors (FIIs) holding a combined 1.78% of the shares. The highest public shareholder is Craft Emerging Market Fund Pcc- Elite Capital Fund, which holds 1.62%. Individual investors collectively own 20.82% of the shares.

What is the technical trend for Vital Chemtech?

As of May 5, 2025, Vital Chemtech's technical trend is mildly bearish, influenced by bearish moving averages and mixed signals from other indicators like the MACD and Bollinger Bands.

As of 5 May 2025, the technical trend for Vital Chemtech has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages remain bearish. The Bollinger Bands and KST are bearish on the weekly timeframe, and the OBV shows a mildly bearish trend. The RSI does not provide any signals on both weekly and monthly timeframes. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the mixed signals from other indicators.

When is the next results date for Vital Chemtech?

No Upcoming Board Meetings

Has Vital Chemtech declared dividend?

Vital Chemtech Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 13, 2024. However, total returns over various periods show significant price declines, with limited contributions from dividends.

Vital Chemtech Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.77%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.14%, the dividend return was 0%, resulting in a total return of -15.14%.<BR><BR>Over the past year, the price return was -15.53%, with a dividend return of 0.67%, leading to a total return of -14.86%.<BR><BR>In the 2-year period, the price return was -43.94%, the dividend return was 0.93%, resulting in a total return of -43.01%.<BR><BR>For the 3-year period, there was no price return, no dividend return, and the total return was 0.0%.<BR><BR>In the 4-year period, the price return was 0%, the dividend return was 0%, and the total return was 0.0%.<BR><BR>Lastly, over the 5-year period, the price return was 0%, the dividend return was 0%, leading to a total return of 0.0%.<BR><BR>Overall, while Vital Chemtech has declared a dividend, the total returns over various periods indicate significant declines in price, with limited dividend contributions in the longer term.